• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,5-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,5-disubstituted thiazoles

Recent Advances in the Study of 2-(2-Aminothiazol-5-yl)acetamide (CAS: 312581-28-5) in Chemical Biology and Pharmaceutical Research

The compound 2-(2-Aminothiazol-5-yl)acetamide (CAS: 312581-28-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. This heterocyclic compound, featuring an aminothiazole core, has been identified as a promising scaffold for the design of novel therapeutic agents. Recent studies have explored its utility in targeting various biological pathways, including anti-inflammatory, antimicrobial, and anticancer activities.

One of the key areas of research has focused on the synthesis and optimization of 2-(2-Aminothiazol-5-yl)acetamide derivatives to enhance their pharmacological properties. A study published in the Journal of Medicinal Chemistry (2023) demonstrated that modifications at the acetamide moiety could significantly improve the compound's bioavailability and target specificity. The researchers employed computational modeling and in vitro assays to identify derivatives with high affinity for protein kinases involved in cancer progression.

In another groundbreaking study, 2-(2-Aminothiazol-5-yl)acetamide was investigated for its role as a building block in the development of small-molecule inhibitors of bacterial efflux pumps. The findings, published in Antimicrobial Agents and Chemotherapy (2024), highlighted the compound's ability to potentiate the activity of existing antibiotics against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus. This research opens new avenues for addressing the global challenge of antibiotic resistance.

Furthermore, recent advancements in structural biology have provided insights into the molecular interactions of 2-(2-Aminothiazol-5-yl)acetamide with its biological targets. X-ray crystallography and NMR studies have elucidated the binding modes of this compound with enzymes such as cyclooxygenase-2 (COX-2) and histone deacetylases (HDACs), offering a rational basis for further drug design. These structural insights are expected to accelerate the development of next-generation therapeutics with improved efficacy and reduced side effects.

Despite these promising developments, challenges remain in the clinical translation of 2-(2-Aminothiazol-5-yl)acetamide-based compounds. Issues such as metabolic stability, toxicity profiles, and scalable synthesis need to be addressed through interdisciplinary collaboration. Ongoing research efforts are focused on overcoming these hurdles, with several derivatives currently in preclinical evaluation. The continued exploration of this compound's potential underscores its importance in the evolving landscape of chemical biology and pharmaceutical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)